Cargando…
Drug diluent and efficacy of methylene blue in septic shock: authors’ reply
Autores principales: | Ibarra-Estrada, Miguel, Kattan, Eduardo, Aguirre-Avalos, Guadalupe, Hernández, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481601/ https://www.ncbi.nlm.nih.gov/pubmed/37670332 http://dx.doi.org/10.1186/s13054-023-04633-0 |
Ejemplares similares
-
Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy
por: Dubey, Dilip, et al.
Publicado: (2023) -
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial
por: Ibarra-Estrada, Miguel, et al.
Publicado: (2023) -
Reply to the letter “Understanding lactate and its clearance during extracorporeal membrane oxygenation for supporting refractory cardiogenic shock patients”
por: Scolari, Fernando Luís, et al.
Publicado: (2023) -
Reply to: “Pitfalls in identifying active catalyst species”
por: Pereira-Hernández, Xavier Isidro, et al.
Publicado: (2020) -
Reply to: Revisiting the origin of octoploid strawberry
por: Edger, Patrick P., et al.
Publicado: (2019)